Different susceptibility of human immunodeficiency virus type 1 to Env gp41-derived synthetic peptides corresponding to the C-terminal heptad repeat region

Microbes and Infection

Volumn 7, Issue 3, 2005, Pages 356-364

  Isarangkura NA, Panasda ^a,b   Li, Gui Mei ^a   Warachit, Jiranan ^a   Iwabu, Yukie ^a   Tsuji, Shoutaro ^a   Auwanit, Wattana ^b   Yamamoto, Daisuke ^c   Goto, Toshiyuki ^d   Hayashi, Yoshio ^e   Kiso, Yoshiaki ^e   Ikuta, Kazuyoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

C34; Env; gp41; HIV 1; Subtype; Syncytium

Indexed keywords

GLYCOPROTEIN GP 41; SYNTHETIC PEPTIDE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CLONE; CELL FUSION; CELL ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENVELOPE GENE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEOTIDE SEQUENCE; PERSISTENT INFECTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STOP CODON; SYNCYTIUM; UNINDEXED SEQUENCE; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS STRAIN;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 20944440401     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.11.011     Document Type: Article

References (38)

1. M. Peeters, and P.M. Sharp Genetic diversity of HIV-1: the moving target AIDS 14 2000 S129 S140
2. T. Leitner Genetic subtypes of HIV-1 G. Myers B. Korber B. Foley K.-T. Jeang J.W. Mellors S. Wain-Hobson Human Retroviruses and AIDS 1996: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences 1996 Los Alamos National Laboratory Los Alamos, NM 28 40 part III
3. WHO Network for HIV Isolation and Characterization HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains AIDS Res. Hum. Retroviruses 10 1994 1327 1343
4. S. Osmanov, C. Pattou, N. Walker, B. Schwardlander, and J. Esparza WHO-UNAIDS Network for HIV Isolation and Characterization, Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000 J. Acquired Immune Defic. Syndr. 29 2002 184 190
5. C.Y. Ou, Y. Takebe, C.C. Luo, M. Kalish, W. Auwanit, C. Bandea, N. De la Torre, J.L. Moore, G. Schochetman, and S. Yamazaki Wide distribution of two subtypes of HIV-1 in Thailand AIDS Res. Hum. Retroviruses 8 1992 1471 1472
6. J.M. Coffin HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Science 267 1995 483 489
7. D.L. Robertson, P.M. Sharp, F.E. McCutchan, and B.H. Hahn Recombination in HIV-1 Nature 374 1995 124 126
8. R. Roggero, V. Robert-Hebmann, S. Harrington, J. Roland, L. Vergne, S. Jaleco, C. Devaux, and M. Biard-Piechaczyk Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediate apoptosis independently of Fas signaling J. Virol. 75 2001 7637 7650
9. H.R. Gelderblom, M. Ozel, and G. Pauli Morphogenesis and morphology of HIV. Structure-function relations Arch. Virol. 106 1989 1 13
10. M. Ozel, G. Pauli, and H.R. Gelderblom The organization of the envelope projections on the surface of HIV Arch. Virol. 100 1988 255 266
11. T. Goto, M. Nakai, and K. Ikuta The life-cycle of human immunodeficiency virus type 1 Micron 29 1998 123 138
12. D.C. Chan, and P.S. Kim HIV entry and its inhibition Cell 93 1998 681 684
13. J.P. Moore, and M. Stevenson New targets for inhibitors of HIV-1 replication Nat. Rev. Mol. Cell Biol. 1 2000 40 49
14. L. Wu, N.P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A.A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 Nature 384 1996 179 183
15. P.L. Jones, T. Korte, and R. Blumenthal Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors J. Biol. Chem. 273 1998 404 409
16. S.A. Gallo, A. Puri, and R. Blumenthal HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process Biochemistry 40 2001 12231 12236
17. Y. He, R. Vassell, M. Zaitseva, N. Nguyen, Z. Yang, Y. Weng, and C.D. Weiss Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites J. Virol. 77 2003 1666 1671
18. D.C. Chan, D. Fass, J.M. Berger, and P.S. Kim Core structure of gp41 from the HIV envelope glycoprotein Cell 89 1997 263 273
19. W. Weissenhorn, A. Dessen, S.C. Harrison, J.J. Skehel, and D.C. Wiley Atomic structure of the ectodomain from HIV-1 gp41 Nature 387 1997 426 430
20. S. Jiang, K. Lin, N. Strick, and A.R. Neurath HIV-1 inhibition by a peptide Nature 365 1993 113
21. C. Wild, T. Oas, C. McDanal, D. Bolognesi, and T. Matthews A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition Proc. Natl. Acad. Sci. USA 89 1992 10537 10541
22. C.T. Wild, D.C. Shugars, T.K. Greenwell, C.B. McDanal, and T.J. Matthews Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus inhibitors of virus infection Proc. Natl. Acad. Sci. USA 91 1994 9770 9774
23. M.K. Lawless, S. Barney, K.I. Guthrie, T.B. Bucy, S.R. Petteway Jr., and G. Merutka HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41 Biochemistry 35 1996 13697 13708
24. J.M. Kilby, S. Hopkins, T.M. Venetta, B. DiMassimo, G.A. Cloud, J.Y. Lee, L. Alldredge, E. Hunter, D. Lambert, D. Bolognesi, T. Matthews, M.R. Johnson, M.A. Nowak, G.M. Shaw, and M.S. Saag Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry Nat. Med. 4 1998 1302 1307
25. Y. Kliger, S.A. Gallo, S.G. Peisajovich, I. Munoz-Barroso, S. Avkin, R. Blumenthal, and Y. Shai Mode of action of an antiviral peptide from HIV-1. Inhibition at a post lipid mixing stage J. Biol. Chem. 276 2001 1391 1397
26. T. Goto, K. Ikuta, J.J. Zhang, C. Morita, K. Sano, M. Komatsu, H. Fujita, S. Kato, and M. Nakai The budding of defective human immunodeficiency virus type 1 (HIV-1) particles from cell clones persistently infected with HIV-1 Arch. Virol. 111 1990 87 101
27. M. Yunoki, K. Maotani-Imai, H. Kusuda, M. Motoyama, S. Miyake, H. Imai, Y.S. Shin, S. Kato, K. Sano, C. Morita, M. Nakai, K. Hirai, and K. Ikuta Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1 Arch. Virol. 116 1991 143 158
28. M.K. Bahmani, M. Kameoka, T. Nakaya, K. Fujinaga, Q. Zhong, H. Takahashi, T. Nakano, M. Nakai, S. Ueda, I.M. Jones, R.B. Luftig, and K. Ikuta Production of doughnut-shaped, protease-defective particles from a human T cell clone carrying a provirus with specific mutations in the env, pol, vpr, and nef genes AIDS Res. Hum. Retroviruses 13 1997 523 526
29. K. Ohki, M. Kishi, Y. Nishino, M. Sumiya, T. Kimura, T. Goto, M. Nakai, and K. Ikuta Non-infectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells J. Acquired Immune Defic. Syndr. 4 1991 1233 1240
30. K. Ikuta, S. Suzuki, H. Horikoshi, T. Mukai, and R.B. Luftig Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis Microbiol. Mol. Biol. Rev. 64 2000 725 745
31. + T cells Microbes Infect. 6 2004 911 918
32. R. Chenna, H. Sugawara, T. Koike, R. Lopez, T.J. Gibson, D.G. Higgins, and J.D. Thompson Multiple sequence alignment with the Clustal series of programs Nucleic Acids Res. 31 2003 3497 3500
33. + T cells is variable among primary isolates of human immunodeficiency virus type 1 AIDS Res. Hum. Retroviruses 10 2002 435 446
34. C.P. Pau, S. Lee-Thomas, W. Auwanit, J.R. George, C.Y. Ou, B.S. Parekh, T.C. Granade, D.L. Holloman, S. Phillips, and G. Schochetman Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand AIDS 7 1993 337 340
35. W. Auwanit, T. Mukai, P.I. Ayuthaya, T. Kurata, and K. Ikuta Full-length sequences of two CRF01_ae (subtype e) HIV-1 isolates from 1995 samples of patients with sexually transmitted diseases in Thailand AIDS Res. Hum. Retroviruses 17 2001 867 871
36. S.L. Hanna, C. Yang, S.M. Owen, and R.B. Lal Variability of critical epitopes within HIV-1 heptad repeat domains for selected entry inhibitors in HIV-infected populations worldwide AIDS 16 2002 1603 1608
37. K. Ikuta, C. Morita, S. Miyake, T. Ito, M. Okabayashi, K. Sano, M. Nakai, K. Hirai, and S. Kato Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens Virology 170 1989 408 417
38. M. Caffrey, M. Cai, J. Kaufman, S.J. Stahl, P.T. Wingfield, D.G. Covell, A.M. Gronenborn, and G.M. Clore Determination of the secondary structure and global topology of the 44 kDa ectodomain of gp41 of the simian immunodeficiency virus by multidimensional nuclear magnetic resonance spectroscopy J. Mol. Biol. 271 1997 819 826